CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to DSKYF

Trastzumab Deruxtecan

Phase 2
Daiichi Sankyo (DSKYF)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Dec '26
DSKYFPhase 2

Trastzumab Deruxtecan Phase 2 Est. Readout

Trastzumab Deruxtecan
Dec 2026~
CT.gov
00%
Drug Information

Target Indication

Ovarian Cancer

Clinical Trial

NCT07340164

Last updated: 8/15/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.